WASHINGTON, March 7 Bostwick Laboratories Inc,
a specialized anatomic pathology laboratory focused on the
diagnosis of cancer, said on Friday it is planning an initial
public offering of as much as $100 million in common stock.
Banc of America Securities LLC, Wachovia Securities,
William Blair & Co, and Cowen & Co will underwrite the IPO,
according to a preliminary offering document filed with the
U.S. Securities and Exchange Commission.
The Glen Allen, Virginia-based company is seeking a Nasdaq
listing under the symbol "BOST" (BOST.O).
(Reporting by John Poirier, editing by Richard Chang)